level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
Hire Dr. Sean V.
Canada

PhD Biochemistry | Expert in pharmaceuticals, clinical trials, oncology and stem cells

Profile Summary
Subject Matter Expertise
Services
Writing Clinical Trial Documentation, Medical Writing, Non-Medical Regulatory Writing, Technical Writing, Newswriting, General Proofreading & Editing
Research Meta-Research, Feasibility Study, Technology Scouting, Fact Checking, Gap Analysis, Scientific and Technical Research, Systematic Literature Review
Consulting Business Strategy Consulting, Scientific and Technical Consulting, Regulatory Consulting
Data & AI Statistical Analysis, Image Processing, Image Analysis, Data Cleaning, Data Processing
Work Experience

Postdoctoral Researcher

McMaster University

- Present

Postdoctoral Researcher

McMaster University

January 2025 - Present

Clinical Trial Manager

Kingsman Scientific Management

May 2019 - September 2020

Education

PhD, Biochemistry

McMaster University

September 2019 - December 2024

Masters of Biomedical Technology

Univerity of Calgary

September 2018 - August 2019

Bachelors in Science (Biochemistry)

McMaster University

September 2013 - April 2018

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Kinga Vojnits, Zhuohang Feng, Paige Johnson, Deanna Porras, Ekta Manocha, Sean Vandersluis, Sibylle Pfammatter, Pierre Thibault, Mick Bhatia (2024). Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs . Cancer Letters.
Allison L. Boyd, Justin Lu, Cameron G. Hollands, Lili Alsostovar, Shiva Murali, Jennifer C. Reid, Wendy Ye, Sean Vandersluis, Paige Johnson, Amro ElRafie, et al. (2023). Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in patients with acute myeloid leukemia . Cell Reports Medicine.
Sean Vandersluis, Jennifer C. Reid, Luca Orlando, Mickie Bhatia (2022). Evidence-based support for phenotypic drug discovery in acute myeloid leukemia . Drug Discovery Today.